HRS

This channel contains news about the Heart Rhythm Society (HRS), including coverage of its annual meeting and links to recently released practice guidelines. The HRS is a leading resource on cardiac pacing and electrophysiology

News | EP Lab

May 13, 2020 — The patient-administered nasal spray drug etripamil did not meet its primary endpoint in treating ...

Home May 13, 2020
Home
News | Implantable Cardioverter Defibrillator (ICD)

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System ...

Home May 08, 2020
Home
News | Atrial Fibrillation

May 8, 2020 – A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of ...

Home May 08, 2020
Home
News | Atrial Fibrillation

May 8, 2020 — Positive 12-month results were announced today from the PINNACLE FLX clinical trial assessing the safety ...

Home May 08, 2020
Home
News

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
News | Atrial Fibrillation

May 8, 2020 — New clinical trial reveals the first-in-human results for paroxysmal or persistent atrial fibrillation (AF ...

Home May 08, 2020
Home
The Boston Scientific Emblem MRI-safe S-ICD system does not require a transvenous lead, leading to fewer complications with this type of ICD.
Feature | Implantable Cardioverter Defibrillator (ICD)

May 8, 2020 — A new clinical trial is the first to compare the safety and efficacy of subcutaneous implantable ...

Home May 08, 2020
Home
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20
Feature

May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or ...

Home May 08, 2020
Home
News | EP Lab

May 1, 2020 — The Heart Rhythm Society (HRS) has created a COVID-19 Task Force to make recommendations related to ...

Home April 30, 2020
Home
Caution Recommended in use of COVID-19 Therapy Using Hydroxychloroquine and Azithromycin in Cardiovascular Disease Patients
Feature | Coronavirus (COVID-19)

April 8, 2020 – The scientific community is learning more about the impact and interaction of cardiovascular diseases ...

Home April 08, 2020
Home
While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2
Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart Rhythm ...

Home April 01, 2020
Home
News

September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...

Home September 17, 2019
Home
Videos | EP Lab

Pierre Qian, MBBS, cardiac electrophysiologist fellow, Brigham and Women's Hospital, explains how his facility is ...

Home July 25, 2019
Home
A physician explaining an implantable cardioverter defibrillator (ICD) to a patient. Image courtesy of Biotronik.
Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell, Editor

This is a brief overview of updates on implantable cardioverter defibrillators (ICD), including new technology ...

Home May 24, 2019
Home
Subscribe Now